Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/01/21
End: 08/15/27
Due: 08/15/28
Phase: N/A
Priority: Normal
Start: 06/21/24
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 10/11/20
End: 05/03/23
Due: 05/03/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer | NCT04943536 | Alessa Therapeutics Inc. | user2@example.com | None | 2021-10-01 | 2027-08-15 | 2028-08-15 | - | - | 2025-07-14 |
| Enzalutamide Implants (Enolen) in Patients With Prostate Cancer | NCT06257693 | Alessa Therapeutics Inc. | user2@example.com | None | 2024-06-21 | 2025-08-31 | 2026-08-31 | - | - | 2025-07-14 |
| A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer | NCT04284761 | Alessa Therapeutics Inc. | user2@example.com | None | 2020-10-11 | 2023-05-03 | 2024-05-03 | - | - | 2025-07-14 |